You are here

myelofibrosis

A Huge Decision Is on Tap for This Little Biotech Stock

A Huge Decision Is on Tap for This Little Biotech Stock

Yahoo/Motley Fool

Flag link:

Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib

Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib

Endpoints

Impact Biomedicines

Flag link:

Gilead Fails to Beat Incyte’s Jakafi Drug

Gilead Fails to Beat Incyte’s Jakafi Drug

Investopedia

Gilead Sciences

Flag link:

Shire bids CTI and its troubled myelofibrosis drug adieu, buying its way out of a deal

Shire bids CTI and its troubled myelofibrosis drug adieu, buying its way out of a deal

Endpoints

Flag link:

Geron shares jump after two positive drug studies

Geron shares jump after two positive drug studies

Marketwatch

essential thrombocythemia

Flag link:

ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival

ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival

TheStreet.com

Flag link:

Baxter and its controversial partner CTI claim a win in PhIII blood cancer study

Baxter and its controversial partner CTI claim a win in PhIII blood cancer study

Fierce Biotech

Flag link:

Johnson & Johnson (JNJ) Strikes $935 Million Deal With Geron Corporation (GERN) To Co-Develop Imetelstat

Johnson & Johnson (JNJ) Strikes $935 Million Deal With Geron Corporation (GERN) To Co-Develop Imetelstat

Bidness Etc.

Flag link:

Incyte Building Blockbuster Drug One Disease At A Time

Incyte Building Blockbuster Drug One Disease At A Time

Investors.com

Flag link:

Geron Collaborates with J&J for Imetelstat

Geron Collaborates with J&J for Imetelstat

Yahoo/Zacks

acute myelogenous leukemia

myelodysplastic syndrome

Flag link:

Geron sells last drug in pipeline to J&J unit

Geron sells last drug in pipeline to J&J unit

Yahoo/Reuters

Flag link:

After A Long Year, An Update on Geron's Myelofibrosis Drug Is Disclosed

After A Long Year, An Update on Geron's Myelofibrosis Drug Is Disclosed

TheStreet.com

Flag link:

FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis

FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis

Yahoo

Flag link:

Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial

Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial

Seeking Alpha

Flag link:

Geron And The Mayo Clinic Working In Parallel To Release Clinical Hold Of Imetelstat

Geron And The Mayo Clinic Working In Parallel To Release Clinical Hold Of Imetelstat

Seeking Alpha

Flag link:

Geron says FDA halts patient enrollment in another cancer trial

Geron says FDA halts patient enrollment in another cancer trial

Yahoo/Reuters

Flag link:

Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary

Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary

Seeking Alpha

clinical trials

Flag link:

Geron Plummets as FDA Halts Development of Blood Disorder Drug

Geron Plummets as FDA Halts Development of Blood Disorder Drug

Bloomberg

Flag link:

Geron Shares React to Imetelstat Mayo Study Update

Geron Shares React to Imetelstat Mayo Study Update

TheStreet.com

Flag link:

Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today

Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today

Motley Fool

Cell Therapeutics

Flag link:

Pages